Search
for
Sort by
Research 31–60 of 68
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Alopecia Areata: Current Treatments and New Directions
- New and Emerging Therapies for Alopecia Areata
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Immune therapies for alopecia areata: evidence and new perspectives
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Human Placenta Extract (HPH) Suppresses Inflammatory Responses in TNF-α/IFN-γ-Stimulated HaCaT Cells and a DNCB Atopic Dermatitis (AD)-Like Mouse Model
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts
- Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
- Effects of natural products on skin inflammation caused by abnormal hormones secreted by the adrenal gland
- Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective study
- Alopecia Areata Associated with Dupilumab: National Database Study
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Research Progress on Construction Technology of 3D Human Skin Models and Its Application Prospects in Dermatology
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives